相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Disrupting the Cdk9/Cyclin T1 heterodimer of 7SK snRNP for the Brd4 and AFF1/4 guided reconstitution of active P-TEFb
Kai Zhou et al.
NUCLEIC ACIDS RESEARCH (2022)
Cyclin-dependent kinase 7/9 inhibitor SNS-032 induces apoptosis in diffuse large B-cell lymphoma cells
Liling Jiang et al.
CANCER BIOLOGY & THERAPY (2022)
Milk Fat Globule-Epidermal Growth Factor-Factor 8 Improves Hepatic Steatosis and Inflammation
Lei Zhang et al.
HEPATOLOGY (2021)
TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B-T cell axis and decreases tumour burden in murine fibrosarcoma
Kavitha Premkumar et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Acute perturbation strategies in interrogating RNA polymerase II elongation factor function in gene expression
Bin Zheng et al.
GENES & DEVELOPMENT (2021)
Dealing with transcription-blocking DNA damage: Repair mechanisms, RNA polymerase II processing and human disorders
Nan Jia et al.
DNA REPAIR (2021)
Transcriptional inhibition by CDK7/9 inhibitor SNS-032 suppresses tumor growth and metastasis in esophageal squamous cell carcinoma
Huishan Zeng et al.
CELL DEATH & DISEASE (2021)
Cyclin-dependent kinase inhibitor roscovitine attenuates liver inflammation and fibrosis by influencing initiating steps of liver injury
Yanjun Liu et al.
CLINICAL SCIENCE (2021)
Improved Recovery from Liver Fibrosis by Crenolanib
Doreen Reichert et al.
CELLS (2021)
P-TEFb as A Promising Therapeutic Target
Koh Fujinaga
MOLECULES (2020)
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
Sudeep Tanwar et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation
Dan Liu et al.
CELL METABOLISM (2020)
Pharmacological Inhibition of Cyclin-Dependent Kinases Triggers Anti-Fibrotic Effects in Hepatic Stellate Cells In Vitro
Anna Huebbers et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The effects of inhibiting the activation of hepatic stellate cells by lignan components from the fruits of Schisandra chinensis and the mechanism of schisanhenol
Xiaoli He et al.
JOURNAL OF NATURAL MEDICINES (2020)
In vivo and in vitro studies using Clonorchis sinensis adult-derived total protein (CsTP) on cellular function and inflammatory effect in mouse and cell model
Shang Mei et al.
PARASITOLOGY RESEARCH (2020)
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
MYC Recruits SPT5 to RNA Polymerase II to Promote Processive Transcription Elongation
Apoorva Baluapuri et al.
MOLECULAR CELL (2019)
Transient induction of Cdk9 in the early stage of differentiation is critical for myogenesis
Vahideh Tarhriz et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease?
Moritz J. Strowitzki et al.
PHARMACOLOGICAL RESEARCH (2019)
Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma
Jing Zhang et al.
MOLECULAR CANCER (2019)
CDK9: A key player in cancer and other diseases
Lia Carolina Franco et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
EGlucocorticoid-induced phosphorylation by CDK9 modulates the coactivator functions of transcriptional cofactor GRIP1 in macrophages
David A. Rollins et al.
NATURE COMMUNICATIONS (2017)
Dynamics of the mammalian cell cycle in physiological and pathological conditions
Claude Gerard et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2016)
Transforming Growth Factor-β Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion
Sounak Gupta et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis
Ts-Ting Lin et al.
JOURNAL OF CONTROLLED RELEASE (2016)
CDK9 and its repressor LARP7 modulate cardiomyocyte proliferation and response to injury in the zebrafish heart
Gianfranco Matrone et al.
JOURNAL OF CELL SCIENCE (2015)
The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction
Xinli Qu et al.
KIDNEY INTERNATIONAL (2015)
Mitotic Transcriptional Activation: Clearance of Actively Engaged Pol II via Transcriptional Elongation Control in Mitosis
Kaiwei Liang et al.
MOLECULAR CELL (2015)
Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers
Loredana Santo et al.
SEMINARS IN ONCOLOGY (2015)
Genetic Analysis of the Structure and Function of 7SK Small Nuclear Ribonucleoprotein (snRNP) in Cells
Koh Fujinaga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Cyclin-dependent kinase inhibitor therapy for hematologic malignancies
Prithviraj Bose et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis
Tatiana Kisseleva et al.
JOURNAL OF HEPATOLOGY (2012)
Accelerated Liver Fibrosis in Hepatitis B Virus Transgenic Mice: Involvement of Natural Killer T Cells
Zixue Jin et al.
HEPATOLOGY (2011)
The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine
E. Walsby et al.
LEUKEMIA (2011)
Altered aquaporin expression and role in apoptosis during hepatic stellate cell activation
Ashley M. Lakner et al.
LIVER INTERNATIONAL (2011)
55K isoform of CDK9 associates with Ku70 and is involved in DNA repair
Hongbing Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Responses in Mantle Cell Lymphoma Cells to SNS-032 Depend on the Biological Context of Each Cell Line
Rong Chen et al.
CANCER RESEARCH (2010)
Loss of clock gene mPer2 promotes liver fibrosis induced by carbon tetrachloride
Peng Chen et al.
HEPATOLOGY RESEARCH (2010)
Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma
Wei-Gang Tong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia
Rong Chen et al.
BLOOD (2009)
SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples
Andrew Conroy et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β Pathways
Claudio Alarcon et al.
CELL (2009)
Keratin mutation predisposes to mouse liver fibrosis and unmasks differential effects of the carbon tetrachloride and thioacetamide models
Pavel Strnad et al.
GASTROENTEROLOGY (2008)
SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor
M. Aktar Ali et al.
NEOPLASIA (2007)
Seliciclib (CYC202, R-roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1
DE MacCallum et al.
CANCER RESEARCH (2005)
Characterization of Cdk955 and differential regulation of two Cdk9 isoforms
SM Shore et al.
GENE (2005)
N-(Cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase -: 2.: N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent
RN Misra et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Hepatocytes express nerve growth factor during liver injury - Evidence for paracrine regulation of hepatic stellate cell apoptosis
F Oakley et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
分享论文
